Fuchs Inbal, Losev Yelena, Mor Zohar, Rubinstein Mor, Polyakov Marina, Wagner Tali, Gobay Tamar, Bayene Ester, Mula Gila, Kaidar-Shwartz Hasia, Dveyrin Zeev, Rorman Efrat, Kaliner Ehud, Perl Sivan Haia
Clalit Health Services, Central District, Rishon LeTsiyon 7528809, Israel.
National Mycobacterium Reference Center, Ministry of Health, Tel Aviv 6810416, Israel.
Microorganisms. 2024 Aug 5;12(8):1592. doi: 10.3390/microorganisms12081592.
Tuberculosis (TB) is the second-most prevalent cause of mortality resulting from infectious diseases worldwide. It is caused by bacteria belonging to the Mycobacterium tuberculosis complex (MTBC). In Israel, TB incidence is low, acknowledged by the WHO as being in a pre-elimination phase. Most cases occur among immigrants from high TB incidence regions like the Horn of Africa and the former Soviet Union (FSU), with occasional outbreaks. The outbreak described in this report occurred between 2018 and 2024, increasing the incidence rate of TB in the region. Control of this outbreak posed challenges due to factors including a diverse population (including Ethiopian immigrants, Israeli-born citizens, and immigrants from other countries), economic and social barriers, and hesitancy to disclose information. The unique multidisciplinary team formed to address these challenges, involving the local TB clinic, district health ministry, health maintenance organization (HMO) infectious disease consultant, neighborhood clinic, and National Mycobacterium Reference Laboratory (NMRL), achieved effective treatment and containment. Whole genome sequencing (WGS) proved pivotal in unraveling patient connections during the outbreak. It pinpointed those patients overlooked in initial field investigations, established connections between patients across different health departments, and uncovered the existence of two distinct clusters with separate transmission chains within the same neighborhood. This study underscores collaborative efforts across sectors that successfully contained a challenging outbreak.
结核病(TB)是全球因传染病导致死亡的第二大常见病因。它由结核分枝杆菌复合群(MTBC)中的细菌引起。在以色列,结核病发病率较低,世界卫生组织(WHO)认为该国处于消除结核病的前期阶段。大多数病例发生在来自结核病高发病率地区的移民中,如非洲之角和前苏联(FSU),偶尔会有疫情爆发。本报告所述的疫情发生在2018年至2024年期间,增加了该地区的结核病发病率。由于多种因素,包括人口多样化(包括埃塞俄比亚移民、以色列出生的公民以及来自其他国家的移民)、经济和社会障碍以及信息披露的犹豫态度,控制此次疫情面临挑战。为应对这些挑战而组建的独特多学科团队,包括当地结核病诊所、地区卫生部、健康维护组织(HMO)传染病顾问、社区诊所和国家分枝杆菌参考实验室(NMRL),实现了有效的治疗和疫情控制。全基因组测序(WGS)在疫情期间查明患者之间的关联方面发挥了关键作用。它找出了在初步现场调查中被忽视的患者,建立了不同卫生部门患者之间的联系,并发现同一社区内存在两个具有不同传播链的不同集群。本研究强调了各部门的合作努力成功控制了一场具有挑战性的疫情。